Actions

US stocks rise as Moderna surges on cancer therapy data; SMI advances 0.36%
Moderna’s mRNA cancer vaccine trial results drove a near-doubling of its share price, while the Dow, S&P 500 and Nasdaq 100 posted modest gains. Swiss equities advanced as geopolitical risks and bond yields weighed on risk appetite.

ASR Nederland posts record H1 2026 profit, raises interim dividend
Dutch insurer's operating capital contribution rose 7.1% to a record €773 million, while net profit climbed 9.8% as solvency improved to 222%.

BKW shares fall after H1 profit drops, 2026 EBIT outlook cut
Swiss energy group BKW reported a 15% drop in H1 EBIT and confirmed a lower-end 2026 earnings target. Shares fell more than 1% as energy market headwinds weighed on performance.

Alfen’s H1 2026 revenue rises 23.6% but shares drop 6.3% on margin concerns
Dutch electrification firm Alfen reported a 23.6% year-over-year revenue increase to €261.5 million in H1 2026, but its stock fell 6.3% after executives flagged margin pressures in energy storage and EV charging.

US stocks slip as Walmart drags; Moderna surges before retreat
S&P 500, Dow and Nasdaq fall after Walmart’s weak quarter and rising oil prices. Moderna jumps 177% before paring gains. SMI also declines as Logitech, Swiss Re drop.

LandBridge shares jump 9.6% on Texas conversion and Barron’s spotlight
Stock surges to a new 52-week high after SEC filing to reincorporate in Texas and a Barron’s article highlighting technical setups in water infrastructure plays.

Kinepolis posts 32.6% H1 2026 revenue jump as cinema demand surges
Net profit more than tripled to EUR 28.1 million on strong box office and in-theater sales growth. Stock nears 52-week high after earnings call.

Tonies SE posts 41% H1 2026 revenue growth as shares dip
Strong sales growth driven by North America and new product launches offset margin compression and sent shares down 4.2% in pre-market trading.

Austevoll Seafood Q2 2026 profit falls short as Peru operations weigh on results
Norwegian seafood group Austevoll Seafood reported an 11% revenue miss and a net loss of 254 million NOK in Q2 2026, as El Niño-driven disruptions in Peru and Chile disrupted pelagic operations.

Greenland Mines shares drop 19% after 1-for-50 reverse split plan
The NASDAQ-listed miner’s stock fell sharply after announcing a reverse stock split to meet Nasdaq’s listing requirements. Operations continue at the Skaergaard gold-palladium project in East Greenland.

Wolfe Research flags Amazon, Alphabet, DoorDash as top stock picks
Analysts highlight cloud computing, digital advertising and food delivery as key sectors for the next 12 months. Amazon’s AWS growth and $18bn Louisiana data center expansion lead the recommendations.

US stocks fall as Walmart drags; Moderna surges then pares gains
Moderna’s shares soar 177% before paring gains to 140% above Tuesday’s close. Walmart’s weak quarter weighs on retail peers. SMI and Swiss indices decline as oil prices rise.

Cosmos Health secures five-year Saudi distribution deal for supplements
Innova Healthcare, majority-owned by Alkhabeer Capital, will exclusively distribute Cosmos Health's Sky Premium Life supplements across Saudi Arabia over a five-year term with an option to renew.

US stocks slip on Walmart earnings, oil prices; SMI extends losses
Walmart shares drop 6% on weak U.S. sales; Deere gains 4% on upbeat outlook. Brent crude hits $94/bbl as Middle East tensions rise. SMI falls 0.45% with Logitech, Swiss Re leading declines.

Medivir posts SEK 253.5m cash position after Q2 2026 earnings
Swedish biotech raises SEK 140m via oversubscribed share issue while advancing fostrox in liver cancer and MIV-711 in rare bone diseases. Net turnover declines to SEK 1.2m.

Greenland Mines approves 1-for-50 reverse stock split, GRML ticker retained
Nasdaq-listed Greenland Mines Ltd will reduce its share count from 158.85 million to 3.18 million under the split, effective Sunday. The move targets compliance with Nasdaq's minimum bid price rule.

Swiss utility BKW shares fall 1.1% on weak H1 2026 results
BKW AG reported a 3.1% drop in operating income to CHF 2.18 billion, with EBITDA and EBIT declining 10.1% and 15.1%, respectively. Net profit rose 7% to CHF 217.6 million.

Ultragenyx shares jump 14% after FDA approves first gene therapy
GENGLYCOS granted accelerated approval for glycogen storage disease type Ia, marking Ultragenyx's fifth FDA authorization and first gene therapy. Shares rose 14% in after-hours trading.

Ethan Allen shares rise 4.5% on $3 special dividend declaration
Home furnishings company declares $3 per share special dividend, totaling $76 million, with record date set for September 2026.

Viking Holdings beats Q2 2026 EPS forecast as bookings surge
Cruise operator posts $1.31 adjusted EPS, 37.9% above estimates, as revenue climbs 16.5% and core capacity reaches 96% for 2026. Net income rises 33% year-over-year.

Cambi’s Q2 2026 profit falls as backlog surges to NOK 1.5 bln
Revenue and EBITDA decline amid project completions, while order intake jumps 442% to NOK 554 million. Backlog grows 58% to NOK 1.5 billion, with 46% slated for delivery beyond 2028.

Cogent Communications stock drops 5% after JPMorgan downgrade
JPMorgan cut its rating to Underweight and slashed the price target to $9, citing weaker-than-expected revenue, execution issues in the Waves business and elevated leverage.

German DAX slips 0.07% as tech weakness weighs on gains
The DAX held near flat levels after overnight losses in semiconductor stocks weighed on European equities, while the MDax and Euro Stoxx 50 also slipped modestly. Infineon led declines among DAX tech names.

JPMorgan downgrades Klarna to Neutral, slashes price target to $18
J.P. Morgan cut Klarna’s rating to Neutral from Overweight and reduced its price target to $18, citing weaker-than-expected growth in Europe and a softer outlook for discretionary spending.

